INVO Fertility Inc
10 hedge funds and large institutions have $564K invested in INVO Fertility Inc in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
25% more funds holding
Funds holding: 8 → 10 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
60% less capital invested
Capital invested by funds: $1.4M → $564K (-$839K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$54.6K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$27.3K |
| 3 |
Jane Street
New York
|
+$27.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$27.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$53K |
| 2 |
CIS
Connors Investor Services
Wyomissing,
Pennsylvania
|
-$52K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$2K |
IVF Hedge Fund Activity: Q4 2022 in Review
10 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in INVO Fertility Inc (IVF) for Q4 2022, worth a combined $564K — down 60% from $1.4M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new IVF positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $54.6K. The largest seller was Bank of New York Mellon, exiting entirely with an estimated $53K sold.
- 10 institutional investors held INVO Fertility Inc (IVF) as of Q4 2022, up from 8 in Q3 2022.
- Funds reported $564K of INVO Fertility Inc stock for Q4 2022, down 60% quarter-over-quarter.
- 4 funds opened new INVO Fertility Inc positions in Q4 2022 and 2 closed out, a net change of +2 holders.
- The largest INVO Fertility Inc buyer in Q4 2022 was Citadel Advisors, an estimated $54.6K added.
- The largest INVO Fertility Inc seller in Q4 2022 was Bank of New York Mellon, an estimated $53K sold.
Based on aggregated 13F filings for Q4 2022.